Global Leukocyte Surface Antigen CD47 Market Research Report 2023

The global Leukocyte Surface Antigen CD47 market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.

North American market for Leukocyte Surface Antigen CD47 is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Leukocyte Surface Antigen CD47 is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global manufacturers of Leukocyte Surface Antigen CD47 include Aurigene Discovery Technologies Ltd, Celgene Corp, Forty Seven Inc, Surface Oncology Inc and Trillium Therapeutics Inc, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Leukocyte Surface Antigen CD47, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Leukocyte Surface Antigen CD47.

The Leukocyte Surface Antigen CD47 market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Leukocyte Surface Antigen CD47 market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Leukocyte Surface Antigen CD47 manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

1.1 Product Overview and Scope of Leukocyte Surface Antigen CD47

1.2 Leukocyte Surface Antigen CD47 Segment by Type

1.2.1 Global Leukocyte Surface Antigen CD47 Market Value Comparison by Type (2023-2029)

1.2.2 B-6H12

1.2.3 ALX-148

1.2.4 CC-90002

1.2.5 PSTx-23

1.2.6 Others

1.3 Leukocyte Surface Antigen CD47 Segment by Application

1.3.1 Global Leukocyte Surface Antigen CD47 Market Value by Application: (2023-2029)

1.3.2 Lymphoma

1.3.3 Ovarian Cancer

1.3.4 Ischemia Reperfusion Injury

1.3.5 Kindney Transplant Rejection

1.3.6 Others

1.4 Global Leukocyte Surface Antigen CD47 Market Size Estimates and Forecasts

1.4.1 Global Leukocyte Surface Antigen CD47 Revenue 2018-2029

1.4.2 Global Leukocyte Surface Antigen CD47 Sales 2018-2029

1.4.3 Global Leukocyte Surface Antigen CD47 Market Average Price (2018-2029)

1.5 Assumptions and Limitations

2.1 Global Leukocyte Surface Antigen CD47 Sales Market Share by Manufacturers (2018-2023)

2.2 Global Leukocyte Surface Antigen CD47 Revenue Market Share by Manufacturers (2018-2023)

2.3 Global Leukocyte Surface Antigen CD47 Average Price by Manufacturers (2018-2023)

2.4 Global Leukocyte Surface Antigen CD47 Industry Ranking 2021 VS 2022 VS 2023

2.5 Global Key Manufacturers of Leukocyte Surface Antigen CD47, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Leukocyte Surface Antigen CD47, Product Type & Application

2.7 Leukocyte Surface Antigen CD47 Market Competitive Situation and Trends

2.7.1 Leukocyte Surface Antigen CD47 Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Leukocyte Surface Antigen CD47 Players Market Share by Revenue

2.7.3 Global Leukocyte Surface Antigen CD47 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3.1 Global Leukocyte Surface Antigen CD47 Market Size by Region: 2018 Versus 2022 Versus 2029

3.2 Global Leukocyte Surface Antigen CD47 Global Leukocyte Surface Antigen CD47 Sales by Region: 2018-2029

3.2.1 Global Leukocyte Surface Antigen CD47 Sales by Region: 2018-2023

3.2.2 Global Leukocyte Surface Antigen CD47 Sales by Region: 2024-2029

3.3 Global Leukocyte Surface Antigen CD47 Global Leukocyte Surface Antigen CD47 Revenue by Region: 2018-2029

3.3.1 Global Leukocyte Surface Antigen CD47 Revenue by Region: 2018-2023

3.3.2 Global Leukocyte Surface Antigen CD47 Revenue by Region: 2024-2029

3.4 North America Leukocyte Surface Antigen CD47 Market Facts & Figures by Country

3.4.1 North America Leukocyte Surface Antigen CD47 Market Size by Country: 2018 VS 2022 VS 2029

3.4.2 North America Leukocyte Surface Antigen CD47 Sales by Country (2018-2029)

3.4.3 North America Leukocyte Surface Antigen CD47 Revenue by Country (2018-2029)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Leukocyte Surface Antigen CD47 Market Facts & Figures by Country

3.5.1 Europe Leukocyte Surface Antigen CD47 Market Size by Country: 2018 VS 2022 VS 2029

3.5.2 Europe Leukocyte Surface Antigen CD47 Sales by Country (2018-2029)

3.5.3 Europe Leukocyte Surface Antigen CD47 Revenue by Country (2018-2029)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Leukocyte Surface Antigen CD47 Market Facts & Figures by Country

3.6.1 Asia Pacific Leukocyte Surface Antigen CD47 Market Size by Country: 2018 VS 2022 VS 2029

3.6.2 Asia Pacific Leukocyte Surface Antigen CD47 Sales by Country (2018-2029)

3.6.3 Asia Pacific Leukocyte Surface Antigen CD47 Revenue by Country (2018-2029)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Leukocyte Surface Antigen CD47 Market Facts & Figures by Country

3.7.1 Latin America Leukocyte Surface Antigen CD47 Market Size by Country: 2018 VS 2022 VS 2029

3.7.2 Latin America Leukocyte Surface Antigen CD47 Sales by Country (2018-2029)

3.7.3 Latin America Leukocyte Surface Antigen CD47 Revenue by Country (2018-2029)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Leukocyte Surface Antigen CD47 Market Facts & Figures by Country

3.8.1 Middle East and Africa Leukocyte Surface Antigen CD47 Market Size by Country: 2018 VS 2022 VS 2029

3.8.2 Middle East and Africa Leukocyte Surface Antigen CD47 Sales by Country (2018-2029)

3.8.3 Middle East and Africa Leukocyte Surface Antigen CD47 Revenue by Country (2018-2029)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4.1 Global Leukocyte Surface Antigen CD47 Sales by Type (2018-2029)

4.1.1 Global Leukocyte Surface Antigen CD47 Sales by Type (2018-2023)

4.1.2 Global Leukocyte Surface Antigen CD47 Sales by Type (2024-2029)

4.1.3 Global Leukocyte Surface Antigen CD47 Sales Market Share by Type (2018-2029)

4.2 Global Leukocyte Surface Antigen CD47 Revenue by Type (2018-2029)

4.2.1 Global Leukocyte Surface Antigen CD47 Revenue by Type (2018-2023)

4.2.2 Global Leukocyte Surface Antigen CD47 Revenue by Type (2024-2029)

4.2.3 Global Leukocyte Surface Antigen CD47 Revenue Market Share by Type (2018-2029)

4.3 Global Leukocyte Surface Antigen CD47 Price by Type (2018-2029)

5.1 Global Leukocyte Surface Antigen CD47 Sales by Application (2018-2029)

5.1.1 Global Leukocyte Surface Antigen CD47 Sales by Application (2018-2023)

5.1.2 Global Leukocyte Surface Antigen CD47 Sales by Application (2024-2029)

5.1.3 Global Leukocyte Surface Antigen CD47 Sales Market Share by Application (2018-2029)

5.2 Global Leukocyte Surface Antigen CD47 Revenue by Application (2018-2029)

5.2.1 Global Leukocyte Surface Antigen CD47 Revenue by Application (2018-2023)

5.2.2 Global Leukocyte Surface Antigen CD47 Revenue by Application (2024-2029)

5.2.3 Global Leukocyte Surface Antigen CD47 Revenue Market Share by Application (2018-2029)

5.3 Global Leukocyte Surface Antigen CD47 Price by Application (2018-2029)

6.1 Aurigene Discovery Technologies Ltd

6.1.1 Aurigene Discovery Technologies Ltd Corporation Information

6.1.2 Aurigene Discovery Technologies Ltd Description and Business Overview

6.1.3 Aurigene Discovery Technologies Ltd Leukocyte Surface Antigen CD47 Sales, Revenue and Gross Margin (2018-2023)

6.1.4 Aurigene Discovery Technologies Ltd Leukocyte Surface Antigen CD47 Product Portfolio

6.1.5 Aurigene Discovery Technologies Ltd Recent Developments/Updates

6.2 Celgene Corp

6.2.1 Celgene Corp Corporation Information

6.2.2 Celgene Corp Description and Business Overview

6.2.3 Celgene Corp Leukocyte Surface Antigen CD47 Sales, Revenue and Gross Margin (2018-2023)

6.2.4 Celgene Corp Leukocyte Surface Antigen CD47 Product Portfolio

6.2.5 Celgene Corp Recent Developments/Updates

6.3 Forty Seven Inc

6.3.1 Forty Seven Inc Corporation Information

6.3.2 Forty Seven Inc Description and Business Overview

6.3.3 Forty Seven Inc Leukocyte Surface Antigen CD47 Sales, Revenue and Gross Margin (2018-2023)

6.3.4 Forty Seven Inc Leukocyte Surface Antigen CD47 Product Portfolio

6.3.5 Forty Seven Inc Recent Developments/Updates

6.4 Surface Oncology Inc

6.4.1 Surface Oncology Inc Corporation Information

6.4.2 Surface Oncology Inc Description and Business Overview

6.4.3 Surface Oncology Inc Leukocyte Surface Antigen CD47 Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Surface Oncology Inc Leukocyte Surface Antigen CD47 Product Portfolio

6.4.5 Surface Oncology Inc Recent Developments/Updates

6.5 Trillium Therapeutics Inc

6.5.1 Trillium Therapeutics Inc Corporation Information

6.5.2 Trillium Therapeutics Inc Description and Business Overview

6.5.3 Trillium Therapeutics Inc Leukocyte Surface Antigen CD47 Sales, Revenue and Gross Margin (2018-2023)

6.5.4 Trillium Therapeutics Inc Leukocyte Surface Antigen CD47 Product Portfolio

6.5.5 Trillium Therapeutics Inc Recent Developments/Updates

7.1 Leukocyte Surface Antigen CD47 Industry Chain Analysis

7.2 Leukocyte Surface Antigen CD47 Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Leukocyte Surface Antigen CD47 Production Mode & Process

7.4 Leukocyte Surface Antigen CD47 Sales and Marketing

7.4.1 Leukocyte Surface Antigen CD47 Sales Channels

7.4.2 Leukocyte Surface Antigen CD47 Distributors

7.5 Leukocyte Surface Antigen CD47 Customers

8.1 Leukocyte Surface Antigen CD47 Industry Trends

8.2 Leukocyte Surface Antigen CD47 Market Drivers

8.3 Leukocyte Surface Antigen CD47 Market Challenges

8.4 Leukocyte Surface Antigen CD47 Market Restraints

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

List of Tables

    Table 1. Global Leukocyte Surface Antigen CD47 Market Value Comparison by Type (2023-2029) & (US$ Million)

    Table 2. Global Leukocyte Surface Antigen CD47 Market Value Comparison by Application (2023-2029) & (US$ Million)

    Table 3. Global Leukocyte Surface Antigen CD47 Market Competitive Situation by Manufacturers in 2022

    Table 4. Global Leukocyte Surface Antigen CD47 Sales (K Pcs) of Key Manufacturers (2018-2023)

    Table 5. Global Leukocyte Surface Antigen CD47 Sales Market Share by Manufacturers (2018-2023)

    Table 6. Global Leukocyte Surface Antigen CD47 Revenue (US$ Million) by Manufacturers (2018-2023)

    Table 7. Global Leukocyte Surface Antigen CD47 Revenue Share by Manufacturers (2018-2023)

    Table 8. Global Market Leukocyte Surface Antigen CD47 Average Price (USD/Pcs) of Key Manufacturers (2018-2023)

    Table 9. Global Key Players of Leukocyte Surface Antigen CD47, Industry Ranking, 2021 VS 2022 VS 2023

    Table 10. Global Key Manufacturers of Leukocyte Surface Antigen CD47, Manufacturing Sites & Headquarters

    Table 11. Global Key Manufacturers of Leukocyte Surface Antigen CD47, Product Type & Application

    Table 12. Global Key Manufacturers of Leukocyte Surface Antigen CD47, Date of Enter into This Industry

    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

    Table 14. Global Leukocyte Surface Antigen CD47 by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Leukocyte Surface Antigen CD47 as of 2022)

    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

    Table 16. Global Leukocyte Surface Antigen CD47 Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 17. Global Leukocyte Surface Antigen CD47 Sales by Region (2018-2023) & (K Pcs)

    Table 18. Global Leukocyte Surface Antigen CD47 Sales Market Share by Region (2018-2023)

    Table 19. Global Leukocyte Surface Antigen CD47 Sales by Region (2024-2029) & (K Pcs)

    Table 20. Global Leukocyte Surface Antigen CD47 Sales Market Share by Region (2024-2029)

    Table 21. Global Leukocyte Surface Antigen CD47 Revenue by Region (2018-2023) & (US$ Million)

    Table 22. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Region (2018-2023)

    Table 23. Global Leukocyte Surface Antigen CD47 Revenue by Region (2024-2029) & (US$ Million)

    Table 24. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Region (2024-2029)

    Table 25. North America Leukocyte Surface Antigen CD47 Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 26. North America Leukocyte Surface Antigen CD47 Sales by Country (2018-2023) & (K Pcs)

    Table 27. North America Leukocyte Surface Antigen CD47 Sales by Country (2024-2029) & (K Pcs)

    Table 28. North America Leukocyte Surface Antigen CD47 Revenue by Country (2018-2023) & (US$ Million)

    Table 29. North America Leukocyte Surface Antigen CD47 Revenue by Country (2024-2029) & (US$ Million)

    Table 30. Europe Leukocyte Surface Antigen CD47 Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 31. Europe Leukocyte Surface Antigen CD47 Sales by Country (2018-2023) & (K Pcs)

    Table 32. Europe Leukocyte Surface Antigen CD47 Sales by Country (2024-2029) & (K Pcs)

    Table 33. Europe Leukocyte Surface Antigen CD47 Revenue by Country (2018-2023) & (US$ Million)

    Table 34. Europe Leukocyte Surface Antigen CD47 Revenue by Country (2024-2029) & (US$ Million)

    Table 35. Asia Pacific Leukocyte Surface Antigen CD47 Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)

    Table 36. Asia Pacific Leukocyte Surface Antigen CD47 Sales by Region (2018-2023) & (K Pcs)

    Table 37. Asia Pacific Leukocyte Surface Antigen CD47 Sales by Region (2024-2029) & (K Pcs)

    Table 38. Asia Pacific Leukocyte Surface Antigen CD47 Revenue by Region (2018-2023) & (US$ Million)

    Table 39. Asia Pacific Leukocyte Surface Antigen CD47 Revenue by Region (2024-2029) & (US$ Million)

    Table 40. Latin America Leukocyte Surface Antigen CD47 Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 41. Latin America Leukocyte Surface Antigen CD47 Sales by Country (2018-2023) & (K Pcs)

    Table 42. Latin America Leukocyte Surface Antigen CD47 Sales by Country (2024-2029) & (K Pcs)

    Table 43. Latin America Leukocyte Surface Antigen CD47 Revenue by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Leukocyte Surface Antigen CD47 Revenue by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Leukocyte Surface Antigen CD47 Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 46. Middle East & Africa Leukocyte Surface Antigen CD47 Sales by Country (2018-2023) & (K Pcs)

    Table 47. Middle East & Africa Leukocyte Surface Antigen CD47 Sales by Country (2024-2029) & (K Pcs)

    Table 48. Middle East & Africa Leukocyte Surface Antigen CD47 Revenue by Country (2018-2023) & (US$ Million)

    Table 49. Middle East & Africa Leukocyte Surface Antigen CD47 Revenue by Country (2024-2029) & (US$ Million)

    Table 50. Global Leukocyte Surface Antigen CD47 Sales (K Pcs) by Type (2018-2023)

    Table 51. Global Leukocyte Surface Antigen CD47 Sales (K Pcs) by Type (2024-2029)

    Table 52. Global Leukocyte Surface Antigen CD47 Sales Market Share by Type (2018-2023)

    Table 53. Global Leukocyte Surface Antigen CD47 Sales Market Share by Type (2024-2029)

    Table 54. Global Leukocyte Surface Antigen CD47 Revenue (US$ Million) by Type (2018-2023)

    Table 55. Global Leukocyte Surface Antigen CD47 Revenue (US$ Million) by Type (2024-2029)

    Table 56. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Type (2018-2023)

    Table 57. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Type (2024-2029)

    Table 58. Global Leukocyte Surface Antigen CD47 Price (USD/Pcs) by Type (2018-2023)

    Table 59. Global Leukocyte Surface Antigen CD47 Price (USD/Pcs) by Type (2024-2029)

    Table 60. Global Leukocyte Surface Antigen CD47 Sales (K Pcs) by Application (2018-2023)

    Table 61. Global Leukocyte Surface Antigen CD47 Sales (K Pcs) by Application (2024-2029)

    Table 62. Global Leukocyte Surface Antigen CD47 Sales Market Share by Application (2018-2023)

    Table 63. Global Leukocyte Surface Antigen CD47 Sales Market Share by Application (2024-2029)

    Table 64. Global Leukocyte Surface Antigen CD47 Revenue (US$ Million) by Application (2018-2023)

    Table 65. Global Leukocyte Surface Antigen CD47 Revenue (US$ Million) by Application (2024-2029)

    Table 66. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Application (2018-2023)

    Table 67. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Application (2024-2029)

    Table 68. Global Leukocyte Surface Antigen CD47 Price (USD/Pcs) by Application (2018-2023)

    Table 69. Global Leukocyte Surface Antigen CD47 Price (USD/Pcs) by Application (2024-2029)

    Table 70. Aurigene Discovery Technologies Ltd Corporation Information

    Table 71. Aurigene Discovery Technologies Ltd Description and Business Overview

    Table 72. Aurigene Discovery Technologies Ltd Leukocyte Surface Antigen CD47 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 73. Aurigene Discovery Technologies Ltd Leukocyte Surface Antigen CD47 Product

    Table 74. Aurigene Discovery Technologies Ltd Recent Developments/Updates

    Table 75. Celgene Corp Corporation Information

    Table 76. Celgene Corp Description and Business Overview

    Table 77. Celgene Corp Leukocyte Surface Antigen CD47 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 78. Celgene Corp Leukocyte Surface Antigen CD47 Product

    Table 79. Celgene Corp Recent Developments/Updates

    Table 80. Forty Seven Inc Corporation Information

    Table 81. Forty Seven Inc Description and Business Overview

    Table 82. Forty Seven Inc Leukocyte Surface Antigen CD47 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 83. Forty Seven Inc Leukocyte Surface Antigen CD47 Product

    Table 84. Forty Seven Inc Recent Developments/Updates

    Table 85. Surface Oncology Inc Corporation Information

    Table 86. Surface Oncology Inc Description and Business Overview

    Table 87. Surface Oncology Inc Leukocyte Surface Antigen CD47 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 88. Surface Oncology Inc Leukocyte Surface Antigen CD47 Product

    Table 89. Surface Oncology Inc Recent Developments/Updates

    Table 90. Trillium Therapeutics Inc Corporation Information

    Table 91. Trillium Therapeutics Inc Description and Business Overview

    Table 92. Trillium Therapeutics Inc Leukocyte Surface Antigen CD47 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 93. Trillium Therapeutics Inc Leukocyte Surface Antigen CD47 Product

    Table 94. Trillium Therapeutics Inc Recent Developments/Updates

    Table 95. Key Raw Materials Lists

    Table 96. Raw Materials Key Suppliers Lists

    Table 97. Leukocyte Surface Antigen CD47 Distributors List

    Table 98. Leukocyte Surface Antigen CD47 Customers List

    Table 99. Leukocyte Surface Antigen CD47 Market Trends

    Table 100. Leukocyte Surface Antigen CD47 Market Drivers

    Table 101. Leukocyte Surface Antigen CD47 Market Challenges

    Table 102. Leukocyte Surface Antigen CD47 Market Restraints

    Table 103. Research Programs/Design for This Report

    Table 104. Key Data Information from Secondary Sources

    Table 105. Key Data Information from Primary Sources

List of Figures

    Figure 1. Product Picture of Leukocyte Surface Antigen CD47

    Figure 2. Global Leukocyte Surface Antigen CD47 Market Value Comparison by Type (2023-2029) & (US$ Million)

    Figure 3. Global Leukocyte Surface Antigen CD47 Market Share by Type in 2022 & 2029

    Figure 4. B-6H12 Product Picture

    Figure 5. ALX-148 Product Picture

    Figure 6. CC-90002 Product Picture

    Figure 7. PSTx-23 Product Picture

    Figure 8. Others Product Picture

    Figure 9. Global Leukocyte Surface Antigen CD47 Market Value Comparison by Application (2023-2029) & (US$ Million)

    Figure 10. Global Leukocyte Surface Antigen CD47 Market Share by Application in 2022 & 2029

    Figure 11. Lymphoma

    Figure 12. Ovarian Cancer

    Figure 13. Ischemia Reperfusion Injury

    Figure 14. Kindney Transplant Rejection

    Figure 15. Others

    Figure 16. Global Leukocyte Surface Antigen CD47 Revenue, (US$ Million), 2018 VS 2022 VS 2029

    Figure 17. Global Leukocyte Surface Antigen CD47 Market Size (2018-2029) & (US$ Million)

    Figure 18. Global Leukocyte Surface Antigen CD47 Sales (2018-2029) & (K Pcs)

    Figure 19. Global Leukocyte Surface Antigen CD47 Average Price (USD/Pcs) & (2018-2029)

    Figure 20. Leukocyte Surface Antigen CD47 Report Years Considered

    Figure 21. Leukocyte Surface Antigen CD47 Sales Share by Manufacturers in 2022

    Figure 22. Global Leukocyte Surface Antigen CD47 Revenue Share by Manufacturers in 2022

    Figure 23. The Global 5 and 10 Largest Leukocyte Surface Antigen CD47 Players: Market Share by Revenue in 2022

    Figure 24. Leukocyte Surface Antigen CD47 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

    Figure 25. Global Leukocyte Surface Antigen CD47 Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Figure 26. North America Leukocyte Surface Antigen CD47 Sales Market Share by Country (2018-2029)

    Figure 27. North America Leukocyte Surface Antigen CD47 Revenue Market Share by Country (2018-2029)

    Figure 28. U.S. Leukocyte Surface Antigen CD47 Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 29. Canada Leukocyte Surface Antigen CD47 Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 30. Europe Leukocyte Surface Antigen CD47 Sales Market Share by Country (2018-2029)

    Figure 31. Europe Leukocyte Surface Antigen CD47 Revenue Market Share by Country (2018-2029)

    Figure 32. Germany Leukocyte Surface Antigen CD47 Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 33. France Leukocyte Surface Antigen CD47 Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 34. U.K. Leukocyte Surface Antigen CD47 Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 35. Italy Leukocyte Surface Antigen CD47 Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 36. Russia Leukocyte Surface Antigen CD47 Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 37. Asia Pacific Leukocyte Surface Antigen CD47 Sales Market Share by Region (2018-2029)

    Figure 38. Asia Pacific Leukocyte Surface Antigen CD47 Revenue Market Share by Region (2018-2029)

    Figure 39. China Leukocyte Surface Antigen CD47 Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 40. Japan Leukocyte Surface Antigen CD47 Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 41. South Korea Leukocyte Surface Antigen CD47 Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 42. India Leukocyte Surface Antigen CD47 Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 43. Australia Leukocyte Surface Antigen CD47 Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 44. Taiwan Leukocyte Surface Antigen CD47 Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 45. Indonesia Leukocyte Surface Antigen CD47 Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 46. Thailand Leukocyte Surface Antigen CD47 Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 47. Malaysia Leukocyte Surface Antigen CD47 Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 48. Philippines Leukocyte Surface Antigen CD47 Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 49. Latin America Leukocyte Surface Antigen CD47 Sales Market Share by Country (2018-2029)

    Figure 50. Latin America Leukocyte Surface Antigen CD47 Revenue Market Share by Country (2018-2029)

    Figure 51. Mexico Leukocyte Surface Antigen CD47 Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 52. Brazil Leukocyte Surface Antigen CD47 Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 53. Argentina Leukocyte Surface Antigen CD47 Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 54. Middle East & Africa Leukocyte Surface Antigen CD47 Sales Market Share by Country (2018-2029)

    Figure 55. Middle East & Africa Leukocyte Surface Antigen CD47 Revenue Market Share by Country (2018-2029)

    Figure 56. Turkey Leukocyte Surface Antigen CD47 Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 57. Saudi Arabia Leukocyte Surface Antigen CD47 Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 58. UAE Leukocyte Surface Antigen CD47 Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 59. Global Sales Market Share of Leukocyte Surface Antigen CD47 by Type (2018-2029)

    Figure 60. Global Revenue Market Share of Leukocyte Surface Antigen CD47 by Type (2018-2029)

    Figure 61. Global Leukocyte Surface Antigen CD47 Price (USD/Pcs) by Type (2018-2029)

    Figure 62. Global Sales Market Share of Leukocyte Surface Antigen CD47 by Application (2018-2029)

    Figure 63. Global Revenue Market Share of Leukocyte Surface Antigen CD47 by Application (2018-2029)

    Figure 64. Global Leukocyte Surface Antigen CD47 Price (USD/Pcs) by Application (2018-2029)

    Figure 65. Leukocyte Surface Antigen CD47 Value Chain

    Figure 66. Leukocyte Surface Antigen CD47 Production Process

    Figure 67. Channels of Distribution (Direct Vs Distribution)

    Figure 68. Distributors Profiles

    Figure 69. Bottom-up and Top-down Approaches for This Report

    Figure 70. Data Triangulation

    Figure 71. Key Executives Interviewed